French biotechnology company developing a yeast-based, in vivo fermentation platform to design and manufacture therapeutic mRNA and self-amplifying RNA at industrial scale
French biotechnology company developing a yeast-based, in vivo fermentation platform to design and manufacture therapeutic mRNA and self-amplifying RNA at industrial scale. Its platform aims to produce longer, naturally matured, high-quality RNA more affordably for oncology, vaccines, gene therapy, and other therapeutic applications.